Fred Schreiber

Florida Hospital Cancer Institute — United States

Medicine · Health Sciences

12h-index661citations24works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(5), Lung Cancer Diagnosis and Treatment(4), Classical Antiquity Studies(3), Prostate Cancer Treatment and Research(3), Tea Polyphenols and Effects(3)

Publications24 total

Abstract PR06: Effect of polyphenon E on progression to prostate cancer after diagnosis of high grade prostatic intraepithelial neoplasia
Cancer Prevention Research·2015
Use of Adjuvant Cisplatin-Based Versus Carboplatin-Based Chemotherapy in Non–Small-Cell Lung Cancer: Findings From the Florida Initiative for Quality Cancer Care
Journal of Oncology Practice·2015· 4 cited
Effect of green tea catechins in prostate cancer chemoprevention.
Journal of Clinical Oncology·2015
Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention
Cancer Prevention Research·2015· 126 citedOpen Access
Florida Initiative for Quality Cancer Care: Changes in Psychosocial Quality of Care Indicators Over a 3-Year Interval
Journal of Oncology Practice·2015· 7 citedOpen Access
Florida Initiative for Quality Cancer Care: Improvements in Breast Cancer Quality Indicators During a 3-Year Interval
Journal of the American College of Surgeons·2014· 15 citedOpen Access
Changes in the Care of Non–Small-Cell Lung Cancer After Audit and Feedback: The Florida Initiative for Quality Cancer Care
Journal of Oncology Practice·2014· 13 cited
Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer
Journal of Clinical Oncology·2013· 143 citedOpen Access
Molecular analysis-directed, international, phase III trial in patients with advanced non-small-cell lung cancer.
Journal of Clinical Oncology·2013· 4 cited
Effects of a Brief Multimedia Psychoeducational Intervention on the Attitudes and Interest of Patients With Cancer Regarding Clinical Trial Participation: A Multicenter Randomized Controlled Trial
Journal of Clinical Oncology·2012· 62 citedOpen Access
Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer
Contemporary Clinical Trials·2011· 18 citedOpen Access
Quality of Care in Non–Small-Cell Lung Cancer: Findings From 11 Oncology Practices in Florida
Journal of Oncology Practice·2011· 12 citedOpen Access
Degree of Variability in Performance on Breast Cancer Quality Indicators: Findings From the Florida Initiative for Quality Cancer Care
Journal of Oncology Practice·2011· 22 citedOpen Access
Quality of Psychosocial Care Indicators
PsycTESTS Dataset·2011· 2 cited
Evaluating the quality of psychosocial care in outpatient medical oncology settings using performance indicators
Psycho-Oncology·2010· 59 citedOpen Access
A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer
Cancer Investigation·2010· 24 cited
The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score: Design and validation.
Journal of Clinical Oncology·2010· 50 cited
Final results of a first line multicenter phase II metastatic breast cancer trial of vinflunine monotherapy and in combination with trastuzumab in HER2+ patients.
Cancer Research·2009· 7 cited
Phase II trial of thalidomide and daily oral dexamethasone for treatment of hormone refractory prostate cancer progressing after chemotherapy
Urologic Oncology Seminars and Original Investigations·2007· 13 cited
Preliminary results of a multicenter phase II trial of vinflunine (with trastuzumab in HER2+ pts) as first-line treatment in metastatic breast cancer
Journal of Clinical Oncology·2007· 12 cited
page 1 of 2Next →

Frequent Co-authors

Paul B. Jacobsen(9), Ji‐Hyun Lee(9), William J. Fulp(9), Merry Jennifer Markham(9), Thomas H. Cartwright(9), Mokenge P. Malafa(9), Richard M. Levine(8), Guillermo Abesada‐Terk(8), R. H. Brown(8), Douglas Faig(8), Carlos Alemany(7), Tawee Tanvetyanon(6), Jhanelle E. Gray(6), David Shibata(6), Erin M. Siegel(6), Philip Sharp(6), Michael J. Schell(5), Gwendolyn P. Quinn(5), George Kim(5), Nagi B. Kumar(4)